{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:24:51Z","timestamp":1794471891984,"version":"4.9.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Microbiology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.vetmic.2020.108890","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T12:05:54Z","timestamp":1602504354000},"page":"108890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Newcastle disease virus vectored rabies vaccine induces strong humoral and cell mediated immune responses in mice"],"prefix":"10.1016","volume":"251","author":[{"given":"Ashis","family":"Debnath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh C","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajai Lawrence","family":"D\u2019silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Batheja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayan","family":"Ramamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram N.","family":"Vakharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhan Mohan","family":"Chellappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohini","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vetmic.2020.108890_bib0005","series-title":"Newcastle Disease World Organisation for Animal Health Manual of Diagnostic Tests and Vaccines for Terrestrial Animals","first-page":"576","author":"Alexander","year":"2008"},{"key":"10.1016\/j.vetmic.2020.108890_bib0010","doi-asserted-by":"crossref","first-page":"692","DOI":"10.4049\/jimmunol.136.2.692","article-title":"Isolation and characterization of human T cell lines and clones reactive to rabies virus: antigen specificity and production of interferon-gamma","volume":"136","author":"Celis","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.vetmic.2020.108890_bib0015","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11262-017-1433-3","article-title":"Rescue of a recombinant Newcastle disease virus strain R2B expressing green fluorescent protein","volume":"53","author":"Chellappa","year":"2017","journal-title":"Virus Genes"},{"key":"10.1016\/j.vetmic.2020.108890_bib0020","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1128\/JVI.02886-12","article-title":"A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein","volume":"87","author":"Chen","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.vetmic.2020.108890_bib0025","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0042-6822(90)90433-R","article-title":"Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD 819","volume":"175","author":"Conzelmann","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.vetmic.2020.108890_bib0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.14202\/vetworld.2019.126-130","article-title":"Serological profiling of rabies antibodies by enzyme-linked immunosorbent assay and its comparative analysis with rapid fluorescent focus inhibition test in mouse model","volume":"12","author":"Debnath","year":"2019","journal-title":"Vet. World"},{"key":"10.1016\/j.vetmic.2020.108890_bib0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/vaccines5040031","article-title":"Newcastle disease virus vectored bivalent vaccine against virulent infectious bursal disease and Newcastle disease of chickens","volume":"5","author":"Dey","year":"2017","journal-title":"Vaccines"},{"key":"10.1016\/j.vetmic.2020.108890_bib0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0966-842X(93)90035-P","article-title":"Antibody-mediated clearance of viruses from the mammalian central nervous system","volume":"1","author":"Dietzschold","year":"1993","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.vetmic.2020.108890_bib0045","first-page":"45","article-title":"Structure and function of rabies virus glycoprotein","volume":"40","author":"Dietzschold","year":"1978","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.vetmic.2020.108890_bib0050","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.vaccine.2009.01.009","article-title":"Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans","volume":"27","author":"DiNapoli","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vetmic.2020.108890_bib0055","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/vaccines7020054","article-title":"New rabies vaccines for use in humans","volume":"7","author":"Ertl","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.vetmic.2020.108890_bib0060","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.arcmed.2011.10.009","article-title":"Intranasal anti-rabies DNA immunization promotes a Th1-related cytokine stimulation associated with plasmid survival time","volume":"42","author":"Feria-Romero","year":"2011","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.vetmic.2020.108890_bib0065","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0301-0082(97)00021-X","article-title":"Interleukin-6 (IL-6)-a molecule with both beneficial and destructive potentials","volume":"52","author":"Gadient","year":"1997","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.vetmic.2020.108890_bib0070","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0042-6822(92)90465-2","article-title":"Rabies virus glycoprotein is a trimer","volume":"187","author":"Gaudin","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.vetmic.2020.108890_bib0075","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1128\/JVI.00519-11","article-title":"Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats","volume":"85","author":"Ge","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.vetmic.2020.108890_bib0080","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tmaid.2013.09.006","article-title":"Immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule using a purified chick embryo cell vaccine: an observational study","volume":"11","author":"Lau","year":"2013","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.vetmic.2020.108890_bib0085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.virusres.2016.05.007","article-title":"A novel rabies virus lipopeptide provides a better protection by improving the magnitude of DCs activation and T cell responses","volume":"221","author":"Liu","year":"2016","journal-title":"Virus Res."},{"key":"10.1016\/j.vetmic.2020.108890_bib0090","doi-asserted-by":"crossref","first-page":"108578","DOI":"10.1016\/j.vetmic.2020.108578","article-title":"AAV-expressed G protein induces robust humoral and cellular immune response and provides durable protection from rabies virus challenges in mice","volume":"242","author":"Liu","year":"2020","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.vetmic.2020.108890_bib0095","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.vaccine.2016.12.069","article-title":"Expression of interleukin-6 by a recombinant rabies virus enhances its immunogenicity as a potential vaccine","volume":"35","author":"Luo","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vetmic.2020.108890_bib0100","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.4049\/jimmunol.162.5.2867","article-title":"Qualitative and quantitative requirements for CD4+ T cell-mediated antiviral protection","volume":"162","author":"Maloy","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.vetmic.2020.108890_bib0105","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1016\/j.vaccine.2018.01.082","article-title":"Evaluation of in vitro inhibitory potential of type-I interferons and different antiviral compounds on rabies virus replication","volume":"37","author":"Marosi","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vetmic.2020.108890_bib0110","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10875-006-9044-0","article-title":"Detection of cellular immunity to rabies antigens in human vaccinees","volume":"26","author":"Moore","year":"2006","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.vetmic.2020.108890_bib0115","first-page":"1154","article-title":"Effect of maternal immunity on the immune response to oral vaccination against rabies in young foxes","volume":"62","author":"M\u00fcller","year":"2001","journal-title":"Am. J. Vet. Med. Res."},{"key":"10.1016\/j.vetmic.2020.108890_bib0120","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12250-016-3734-4","article-title":"Immunogenicity of multi-epitope-based vaccine candidates administered with the adjuvant Gp96 against rabies","volume":"31","author":"Niu","year":"2016","journal-title":"Virol. Sin."},{"key":"10.1016\/j.vetmic.2020.108890_bib0125","series-title":"Manual of Diagnostic Tests and Vaccines for Terrestrial Animals: Mammals, Birds and Bees, Biological Standards Commission","first-page":"555","author":"OIE","year":"2012"},{"key":"10.1016\/j.vetmic.2020.108890_bib0130","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/vaccines7030110","article-title":"The cellular immune response to rabies vaccination: a systematic review","volume":"7","author":"Overduin","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.vetmic.2020.108890_bib0135","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/vr.123.19.481","article-title":"First field trial of fox vaccination against rabies using a vaccinia-rabies recombinant virus","volume":"123","author":"Pastoret","year":"1988","journal-title":"Vet. Rec."},{"key":"10.1016\/j.vetmic.2020.108890_bib0140","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.vetmic.2020.108890_bib0145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/pathogens8030145","article-title":"Recombinant Newcastle Disease Virus (NDV) expressing Sigma C protein of Avian Reovirus (ARV) protects against both ARV and NDV in chickens","volume":"8","author":"Saikia","year":"2019","journal-title":"Pathogens"},{"key":"10.1016\/j.vetmic.2020.108890_bib0150","first-page":"32","article-title":"An epidemiological study of animal bites in India: results of a WHO sponsored national multi-centric rabies survey","volume":"38","author":"Sudarshan","year":"2006","journal-title":"J. Commun. Dis."},{"key":"10.1016\/j.vetmic.2020.108890_bib0155","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/clin.1994.1088","article-title":"Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man","volume":"71","author":"Thraenhart","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.vetmic.2020.108890_bib0160","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1586\/erv.11.79","article-title":"Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors","volume":"10","author":"Walsh","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.vetmic.2020.108890_bib0165","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.vetmic.2020.108890_bib0170","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.virol.2013.12.029","article-title":"Protection of non-human primates against rabies with an adenovirus recombinant vaccine","volume":"450","author":"Xiang","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.vetmic.2020.108890_bib0175","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.micpath.2018.03.038","article-title":"Generation and evaluation of a recombinant Newcastle disease virus strain R2B with an altered fusion protein cleavage site as a vaccine candidate","volume":"118","author":"Yadav","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.vetmic.2020.108890_bib0180","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.vaccine.2007.12.050","article-title":"A recombinant pseudorabies virus expressing rabies virus glycoprotein: safety and immunogenicity in dogs","volume":"26","author":"Yuan","year":"2008","journal-title":"Vaccine"}],"container-title":["Veterinary Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378113520310282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378113520310282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T23:10:16Z","timestamp":1759878616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378113520310282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":36,"alternative-id":["S0378113520310282"],"URL":"https:\/\/doi.org\/10.1016\/j.vetmic.2020.108890","relation":{},"ISSN":["0378-1135"],"issn-type":[{"value":"0378-1135","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Newcastle disease virus vectored rabies vaccine induces strong humoral and cell mediated immune responses in mice","name":"articletitle","label":"Article Title"},{"value":"Veterinary Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vetmic.2020.108890","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108890"}}